{"id":"W2036488279","doi":"10.1016/j.jaad.2004.09.029","title":"Extended efalizumab therapy improves chronic plaque psoriasis: Results from a randomized phase III trial","year":2005,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":213,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Randomized controlled trial; Dermatology; Plaque psoriasis; Internal medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005872948,0.0003457908,0.002235132,0.000243785,0.0001510274,0.00001051266,0.0008786749,0.0003334816,0.0001017824],"category_scores_gemma":[0.0003022774,0.0002054855,0.0009727365,0.0002548146,0.001218891,0.0001587844,0.00008703046,0.0006853723,0.00003204022],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001009131,"about_ca_system_score_gemma":0.0003025912,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000100308,"about_ca_topic_score_gemma":0.000006258317,"domain_scores_codex":[0.9953222,0.001975205,0.001847971,0.0002885438,0.0001254249,0.0004406566],"domain_scores_gemma":[0.9940156,0.001532394,0.00402886,0.0002955848,0.00007124269,0.00005630965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7605702,0.0006152425,0.00001023003,0.000003400728,0.002985435,0.00001211658,0.0005988682,0.000005672121,0.1312948,0.0001294631,0.004301974,0.09947268],"study_design_scores_gemma":[0.7504944,0.000710445,0.0002529192,0.00004274218,0.0006936226,0.0009754902,0.0001409893,0.00001374989,0.2233755,0.0004209391,0.02269126,0.000187924],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9694189,0.01571281,0.00005723372,0.01284289,0.001047297,0.0006607821,0.0001080683,0.00002404638,0.0001279417],"genre_scores_gemma":[0.9920729,0.006092423,0.0003407583,0.0006846908,0.0005586733,0.00002965129,0.00001599113,0.00002505515,0.0001798195],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09928475,"threshold_uncertainty_score":0.8379454,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01780253160628653,"score_gpt":0.298222103744109,"score_spread":0.2804195721378224,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}